Kaerus Bioscience

Activities: Research & Development Digital

Trending Articles

  1. Custom Pharmaceuticals launches new company to foster breakthrough drug development and strategic partnerships Custom Pharmaceuticals Ltd has launched Centrix Pharma Solutions, a new company dedicated to accelerating drug product development through collaboration with biotech firms and...
  2. Owen Mumford launches EcoSafe safety syringe platform Medical device expert Owen Mumford has extended its 1 mL safety syringe platform by adding a companion reusable autoinjector.
  3. Compliance ≠ Quality: why “meeting the standard” isn’t enough In pharma manufacturing, regulatory compliance is non-negotiable. Whether it’s 21 CFR Part 11, EU Annex 11, or PIC/S PE-009, every manufacturer understands the need for...
  4. Eli Lilly to build a new $3bn facility to boost oral medicine manufacturing capacity in Europe The Netherlands site will bring 500 manufacturing and 1500 construction jobs while further strengthening Lilly's global supply chain
  5. Aragen appoints Neeraj Garg as CEO to lead Discovery Solutions business Life sciences veteran joins to drive strategic growth and innovation at Aragen

Related Content

Research & Development

Servier acquires potential treatment for Fragile X syndrome

KER-0193, a novel, orally bioavailable small molecule, was granted orphan drug and rare paediatric drug designation by the US FDA
Research & Development

Neurolentech partners with Kaerus Bioscience to advance neurodevelopmental disorder research

Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes
Subscribe now